Research programme: antifungals - Pcovery
Latest Information Update: 28 Jul 2018
At a glance
- Originator Pcovery
- Class
- Mechanism of Action Membrane protein modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Mycoses